NCT02471170View on ClinicalTrials.gov

Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 10, 2015

Primary Completion Date

January 1, 2035

Study Completion Date

January 1, 2035

Conditions
Pancreatic Diseases
Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER